PNC Financial Services Group
VOR icon

PNC Financial Services Group’s Vor Biopharma VOR Stock Holding History

PNC Financial Services Group’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67K Buy
308
+62
+25% +$938 ﹤0.01% 4339
2026
Q1 		$4.39K Buy
+246
New +$3.47K ﹤0.01% 4323
2021
Q4 		– Sell
-100
Closed -$31K – 4628
2021
Q3 		$31K Buy
100
+50
+100% +$14.9K ﹤0.01% 3332
2021
Q2 		$19K Buy
+50
New +$24.7K ﹤0.01% 3502

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

PNC Financial Services Group's VOR Position: Q2 2026 in Review

PNC Financial Services Group increased its Vor Biopharma (VOR) stake by 25% in Q2 2026, buying an estimated $938 and bringing the position to 308 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #4339.

PNC Financial Services Group first reported a position in VOR in Q2 2021 and has held it in 4 quarters since. The position peaked at $31K in Q3 2021. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • PNC Financial Services Group held 308 shares of Vor Biopharma worth $5.67K as of Q2 2026.
  • PNC Financial Services Group bought 62 Vor Biopharma shares in Q2 2026, an estimated $938.
  • Vor Biopharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4339 holding.
  • PNC Financial Services Group first reported a position in Vor Biopharma in Q2 2021 and has held it in 4 quarters since.
  • PNC Financial Services Group's Vor Biopharma position peaked at $31K in Q3 2021.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.